Top 5 CRISPR Stocks To Invest In

Page 5 of 5

1. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 73

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company engaged in discovering, developing, manufacturing, and selling medicines and vaccines worldwide. The company’s portfolio includes products in therapeutic areas such as cardiovascular, metabolic, infectious diseases, women’s health, and COVID-19 prevention and treatment. It is one of the best gene editing stocks to monitor. 

On July 6, 2023, Pfizer Inc. (NYSE:PFE) invested $25 million in Caribou Biosciences, expressing confidence in the gene-editing company and providing additional funding for its experimental multiple myeloma treatment, CB-011. The investment is earmarked for advancing CB-011, currently in Phase 1 testing for relapsed or refractory multiple myeloma patients. In return, Pfizer Inc. (NYSE:PFE) obtains a right of first negotiation if Caribou explores discussions with potential partners for CB-011. This investment not only boosts investor sentiment but also brings Pfizer’s developmental expertise to support Caribou’s efforts.

According to Insider Monkey’s third quarter database, 73 hedge funds were bullish on Pfizer Inc. (NYSE:PFE), same as the prior quarter. D E Shaw is the leading stakeholder of the company, with 13.15 million shares worth $436.2 million. 

Smead Value Fund made the following comment about Pfizer Inc. (NYSE:PFE) in its Q3 2023 investor letter:

“Through the first nine months of the year, we had a gain of 2.10%. The S&P 500 had a gain of 13.07% and the Russell 1000 Value had a gain of 1.79%. The stock market realized markedly higher riskless US Treasury interest rates had their effect on the stock market as it began to reassert what Warren Buffett calls the “gravitational pull” on price-to-earnings ratios (P/E).

On the downside, Target (TGT), Bank of America (BAC) and Pfizer Inc. (NYSE:PFE) detracted the most in the first nine months of the year. Pfizer (PFE) is suffering from a fall-off in Covid-19 vaccinations and we are trying to figure out what to do with it as a small holding.”

Follow Pfizer Inc (NYSE:PFE)

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out 13 Best Big Company Stocks to Buy and 12 Highest-Paid Women CEOs

Page 5 of 5